Delivery Order SPE2DB20D2014-SPE2DB25FC96K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Cefazolin 2 G/50 ML with dextrose solution, valued at $2,200.41. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The award utilized no set-aside designation, indicating competitive procurement. Performance will occur at AmerisourceBergen's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solution, valued at $1,200.22. This firm fixed price delivery order, which will be completed by August 13, 2025, represents a pediatric or small-volume pharmaceutical procurement with performance in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $6,142.80 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextroses on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 1 G/50 ML-Dextroses with a ceiling value of $6,334.87. This contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,904.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 1GM 25S, an antibiotic pharmaceutical product. The contract was competitively awarded without a set-aside designation and has an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.50 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextrose solution. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on February 20, 2025, with an ultimate completion date of February 21, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters location. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC96KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cefazolin 2 G/50 ML with dextrose solution. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive set-aside award, issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's comprehensive $999.99 billion indefinite delivery vehicle (SPE2DX) with the Defense Logistics Agency, which extends through December 2026. The parent contract serves as a global pharmaceutical support mechanism enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare systems and other federal customers. Cefazolin, a broad-spectrum antibiotic commonly used in military medical operations, represents a typical commodity within AmerisourceBergen Drug Corp's federal pharmaceutical supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/10/25 |